Mercury set to close fully covered
Syndication of the £235m of loans backing Cinven’s buy-out of Mercury Pharma is to close oversubscribed as bankers continue to praise issuance conditions in the leveraged loan market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
